25.09  0.43 (1.74%)		08-06 16:00
Open: 25.05 High: 25.09 Volume: 28,153		Pre. Close: 24.66 Low: 24.7501 Market Cap: 25(M)

Short term
Mid term
Targets	6-month :	29.69	1-year :	34.67
Resists	First :	25.42	Second :	29.69
Pivot price	23.92
Supports	First :	22.92	Second :	21.38
MAs	MA(5) :	24.11	MA(20) :	23.86
	MA(100) :	20.56	MA(250) :	18.35
MACD	MACD :	0.4	Signal :	0.4
%K %D	K(14,3) :	67.5	D(3) :	45.3
RSI	RSI(14): 65.3
52-week	High :	25.42	Low :	13.95

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ PSIL ] has closed Bollinger Bands are 28.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	25.13 - 25.23	25.23 - 25.33
Low:	24.5 - 24.61	24.61 - 24.71
Close:	24.92 - 25.1	25.1 - 25.29

This actively managed Exchange Traded Fund (ETF) endeavors to meet its investment goals by typically allocating a minimum of 80% of its total net assets (including any capital secured through borrowing for investment purposes) into the securities of specific companies. To be eligible for inclusion, these companies must either derive at least half of their net revenue from, or commit 50% or more of their assets to, psychedelic compounds, their derivatives, or other financial instruments exhibiting similar economic characteristics. The fund's primary holdings consist of publicly traded life sciences firms focused on psychedelic medical treatments, in addition to other businesses involved in the broader psychedelics sector. It is important to note that this fund maintains a concentrated, non-diversified portfolio.

Wed, 05 Aug 2026
Discipline and Rules-Based Execution in PSIL Response - Stock Traders Daily

Fri, 24 Jul 2026
Behavioral Patterns of PSIL and Institutional Flows - Stock Traders Daily

Thu, 28 May 2026
Watch Drilldown: AdvisorShares Psychedelics ETF - Bloomberg

Mon, 27 Apr 2026
New Executive Orders Boost Weed and Psilocybin ETFs - thedailyupside.com

Fri, 24 Apr 2026
Executive Order Sparks New Phase for Psychedelic Biotech, but Risks Remain - Investing News Network

Thu, 23 Apr 2026
3 Different Ways to Play the Rally in Psychedelic Stocks - TheStreet Pro

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: AMEX
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.